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For an infectious disease like tuberculosis, which
is transmitted by aerosol droplets, the rapid and
accurate detection of M.tuberculosis is essential,
not only to speed up the treatment of the patient
but also to control the spread of the disease.
Tuberculosis in childhood occurs with different
manifestations. All these forms of tuberculosis,
except when cavitation occurs in pulmonary
tuberculosis, are paucibacillary in nature. For
this reason, even though at the present time
bacteriological confirmation is still the final
proof of tuberculous disease, it is difficult to
obtain.
Depending on the form of disease manifestation,
several specimens like sputum and/or gastric
lavage, as children are often unable to produce
sputum, lymph nodes and other biopsy speci-
mens, pus, ascitic fluid, pleural or cerebrospinal
fluid (CSF) need to be collected. If delay is
anticipated, relevant specimens may be collected
in suitable transport medium for sending it to the
laboratory.
There are two ways to address diagnosis of
tuberculosis. The direct approach is concerned
with the detection of the bacteria by microscopy
or culture, detection of tuberculostearic acid (bac-
terial wall component), detection and identifica-
tion of mycobacterial antigen by the use of
polyclonal or monoclonal antibodies, analysis of
lipid composition by chromatography, and the
detection of DNA or RNA of mycobacterial
origin by hybridization with a DNA probe with
or without amplification of nucleic acids. The
indirect approach relates to measurement of host
immune response against the mycobacteria. This
includes humoral immunity via the detection of
antibodies against the bacteria and cellular re-
sponse via skin tests.
TRADITIONAL APPROACH
1. Microscopy
Microscopy is the simplest and most rapid proce-
dure currently available to detect acid-fast bacilli
(AFB) in clinical specimens by Ziehl Neelsen or
Kinyoun staining procedure. The limit of detec-
tion with this method is 5000-10,000 bacteria per
ml of sputum. Introduction of fluorochrome dyes
such as Auramine O in place of the traditional
basic fuchsin dyes made smear reading advanta-
geous as the yellow-fluorescing bacilli are easier
to detect than the red fuchsin-stained organisms
seen in Ziehl-neelsen or Kinyoun staining. Fur-
ther, in the fluorescent microscopy, smears are
read in low power so that larger areas are screened
in less time. The results of smear microscopy can
be influenced by many factors such as the type of
counter stain used, and the training and experience of the
person evaluating the smear. A new approach to
increase the smear sensitivity is to use
cytocentrifuges1. The main advantage of sputum
smear microscopy is that it is inexpensive, well-
established, extremely reliable and results can be
reported within hours of receipt of the sample.
However, viability of the organism and species
identification are not possible with this tech-
nique.
II. CultureandDrugSusceptibility
Isolation of mycobacteria from clinical speci-
mens has solely depended on the use of media
such as the egg-based Lowenstein- Jensen (LJ)
medium, Middlebrook 7H11 agar, Middlebrook
7 H9 broth and Kirchner’s liquid medium. The
major constraint of this procedure is the slow
growth of mycobacteria with necessitates a
mean incubation period of 4 weeks on these
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MODERN APPROACHES
Today, there are a few rapid methods for the
culture of mycobacteria. These include
microcolony detection on solid media, the Septi-
chek AFB method, mycobacterial growth indi-
cator tuber (MGIT) system, radiometric Bactec
460 TB method and Bactec MGIT 960 method.
I.Microcolonycountingmethod
In this method, plates poured with thin layer of
Middlebrook 7H11 agar medium are inoculated
and examined microscopically on alternate days
for the first 2 weeks and less frequently thereaf-
ter. For microscopic examination, the plates are
inverted on the stage of a conventional micro-
scope and the objective is focused on the surface
of the agar. In less than 7 days, microcolonies of
slow growing mycobacteria such as
M.tuberculosis can be detected using this method.
Though this method is less expensive and re-
quires about half the time needed for conven-
tional culture, the recovery of mycobacteria is
less efficient and it is labour intensive2. However,
sensitivity of sputum microscopy is limited in
detecting AFB in extra-pulmonary specimens
especially in pauciba-cillary specimens such as
gastric lavage, bron-chioalveolar lavage, CSF
and urine samples etc.
II. Septi-checkAFBsystem
It consists of a liquid phase 7H9 broth with three
solid media, the Middlebrook 7H11 agar, modi-
fied egg medium and chocolate agar. This biphasic
medium is presented in a self contained CO2
environment. This non-radiometric approach has
the potential to expedite processing, obviate CO2
incubation requirements and facilitates early
detection of positive cultures. This method re-
quires about three weeks of incubation. The
unique advantage of this technique is the simul-
taneous detection of M.tuberculosis, non-tuber-
culous mycobacteria (NTM), other respiratory
pathogens and even contaminants. It has been
reported from multicentric studies conducted by
different groups that this system gives a better
culture result when compared to other methods
including BACTEC3.
III.Mycobacterial growth indicator tuber
(MGIT)system
It is a non-radiometric broth method for the
growth and detection of mycobacteria from clini-
cal specimens. The MGIT system consists of a
Middlebrook 7H9 broth and a fluorescent com-
pound embedded in silicone. Antibacterial, anti-
fungal agents and growth supplements are added
before inoculation. Positive cultures are detected
visually because of the metabolic depletion of
oxygen, which otherwise quenches fluorescence.
Instrumen-tation is not required, and multiple
tubes can be inspected simultane-ously. The tube
is examined under UV light where the growth is
indicated by an unmistak-able orange fluorescent
glow. In several studies conducted elsewhere, it
was found that the culture sensitivity of this
method in both smear positive and smear nega-
tive samples compared well with the BACTEC
460 and it was better than the conventional egg
based method 4.
IV. RadiometricBACTEC460TBmethod
Middlebrook et al developed this technique which
is specific for mycobacterial growth, wherein C14
labelled palmitic acid in 7H12 medium is used.
This system detects the presence of mycobacteria
based on their metabolism rather than their
visible growth. When the 14C-labelled substrate
present in the medium is metabolized, 14CO2 is
produced and measured by the BACTEC 460
instrument and reported in terms of growth
index (GI) value. In addition to detecting myco-
bacteria, BACTEC system is also useful in the
identification of M.tuberculosis using the spe-
cific inhibitor p-nitro-alpha-acetylamino-
betahydroxy propiophenone (NAP). The NAP
differential procedure has been shown to be a
rapid and reliable method for identifying
M.tuberculosis. Using the same system, drug
susceptibility tests can be performed for all the
antituberculosis drugs when sufficient growth
index (GI) is observed. Mycobacteria in clinical
samples can be detected in half the time that is
needed for conventional culture methods.
A comparison of the BACTEC radiometric
method with the conventional culture and drug
susceptibility testing methods on isolated from
clinical specimens was recently published from
Tuberculosis Research Centre, Chennai. The
results showed that the rate of isolation of posi-
Ligase chain reaction
system has been
developed which can
further improve the
confirmation of M.
tuberculosisgrowth by
BACTEC system even
when there is low
growth index
Tostoli E, et al
J Clin Microbiol
1998; 36: 2791 -2.
Sensitivity of sputum
microscopy is limited
in detecting AFB in
extrapulmonary
specimens such as
gastric lavage,
bronchioalveolar
lavage, CSF and
urine.
conventional media. The drug susceptibility  tests
to  the  antituberculosis drugs require additional 4
weeks before results can be obtained.
tive cultures was significantly faster with the
BACTEC method, with 87% of the positives
being obtained by 7 days, and 96% by 14 days.
There was a good correlation in drug susceptibil-
ity tests and most of these results became avail-
able within 8 days by the BACTEC methods. By
facilitating early diagnosis, the BACTEC method
may prove to be cost effective in a population
with a high prevalence of tuberculosis 3.5.
V. BACTEC ® MGIT 960 mycobacteria detection
system
It is an automated system for the growth and
detection of mycobacteria with a capacity to
incubate and continuously monitor 960 MGIT
culture tubers. The culture tuber contains same
Middlebrook 7H9 broth base. OADC enrich-
ment and PANTA antibiotic mixture as does the
manual MGIT, except that the final volume here
is 7ml. After adding 0.5 ml inoculum of the
processed specimen, the tuber are incubated at
37oC in the BACTEC MGIT 960 instrument,
and are monitored automatically every 60 min-
utes for increase in fluorescence. Growth detec-
tion is based on the AFB metabolic O2 utilization
and subsequent intensification of an O2 quenched
fluorescent dye contained in a tube of modified
MGIT. A series of algorithms are used to deter-
mine presumptive positivity and alert the opera-
tor to the presence and location of positive tubes.
In a multi-centre evaluation of the BACTEC
MGIT 960 system, three high-volume testing
sites in USA compared the growth and recovery
of AFB to that of the BACTEC 460 TB and
conventional culture. Comparison of average
time of detection between paired specimens
showed that, the BACTEC 460 TB and BACTEC
MGIT 960 systems were 8.7 versus 8.6 for MAC
and 13.4 versus 15.5 days for M.tuberculosis
respectively. According to these investigators the
BACTEC MGIT 960 system exhibits greater
potential as a rapid, accurate and cost effective
method for a high volume AFB laboratory6.
SPECIES IDENTIFICATION
The conventional identification procedures in-
clude tests such as determination of growth rate,
growth at different temperatures, colony mor-
phology, pigment production and susceptibility
to para-nitrobenzoic acid (PNB). The main dis-
advantage here is that species identification takes
an additional 4 weeks using these methods.
NEWER METHODS FOR SPECIES IDENTIFICATION
I. High performance liquid chromatography
(HPLC)
In this technique, the pattern of long chain high
molecular weight fatty acids unique to mycobac-
teria and related genera, namely the mycolic
acids, is generated and compared using an auto-
mated chromatograph after extraction of the
lipid component of the mycobacterial cells using
standardized protocols. These patterns have been
found to be species-specific thus allowing rapid
identification of mycobacterial cultures. Soft-
ware based on mycolic acid patterns for correct
identification of the most commonly encoun-
tered mycobacterial species in the clinical labo-
ratory is now commercially available. This
method is reliable, easy to perform and less
expensive than DNA based identification meth-
ods such as DNA probes and PCR. However, this
technique requires considerable expertise7.
II. DNA probes
The nucleic acid base-pairing is intrinsically
very specific and nucleic acid probes have been
developed which are capable of recognizing spe-
cific portions of DNA or RNA. The choice of the
target DNA sequence for a DNA probe deter-
mines the specificity and sensitivity of the test.
The probe can consist of a fragment of the
mycobacterial genome, a cloned DNA fragment
or a synthetic oligonucleotide. The nature of the
probe influences its specificity. The sensitivity of
the probe depends on the detection system and
the copy number of the target sequence in the
genome. Usually better results are obtained if the
probe is targeted to sequences present in multiple
copies in the target cell (in this case the mycobac-
terium) or if the target sequence is present in the
form of repetitive DNA or robosomal RNA. Com-
mercially available DNA probes hybridize to
species-specific rRNA sequences of
M.tuberculosis, M.avium-intracellulare,
M.kansaii or M. gordonae. The mycobacterial
probes developed by Gen-Probe (San Diego, CA)
were originally labelled with 125I and required
physiological separation of hybridized and
unhybridized probe before detection in the gamma
counter. Now the commercial probes use a
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The rate of
isolation of
positive cultures
was significantly
faster with the
BACTEC method,
with 87% of the
positives being
obtained by 7
days, and 96% by
14 days.
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rated by adding a chemical ‘selection’ agent. The
chemiluminescent procedure requires a nominal
time of 45 minutes and the acridinium ester label
is more stable and extends the shelf life of the
probe reagent to about 6 months. However, these
probes still require about 1-3 x 107 bacilli for a
positive test result while traditional culture tech-
niques require about 10-2 bacilli/ml of specimen.
This indicates that RNA as a target may not
provide the required sensitivity of direct detec-
tion of mycobacteria in clinical samples. An-
other method using solid phase (nylon mem-
brane) non radioactive DNA hybridization has
been developed for identifying M.tuberculosis
and M.avium-intracellulare by Sygene Inc. (San
Diego, CA). This method uses oligonucleotide
probes with an alkaline phosphatase label and
hybridization of the probe to the target is detected
with a chromogenic substrate (reduction of
nitroblue tetrazolium)8.
III. Nucleic acidamplification
Nucleic acid (DNA or RNA) amplification tech-
niques can detect and identify mycobacteria di-
rectly in clinical samples. The most commonly
used method is the polymerase chain reaction
(PCR). In this technique, target DNA sequences
are exponentially amplify in repeated cycles of
DNA synthesis driven by specific oligonucle-
otide primers. The amplified DNA is usually
detected by agarose gel electrophoresis. Today,
many PCR assays are available for the detection
of M.tuberculosis complex in clinical samples.
The most common of these is the one using the
insertion sequence IS6110 which is present only
in mycobacteria belonging to the M.tuberculosis
complex. Like microscopy, PCR results can be
obtained within 24 hours of receipt of the sample.
It is, however, important to remember that
sensitivity and rate of correct identification varies
widely between different laboratories.
The current commercially available amplifica-
tion tests are expensive and do not have any
control for inhibitors of amplification. This may
produce false-negative reactions. The main ad-
vantage of this technique over conventional
microscopy and culture is the speed with which
the diagnosis can be made and direct identifica-
tion of the infecting mycobacterium.
A recent modification of nucleic acid amplifica-
tion is the strand displacement amplification
(SDA) method which is an isothermal, in vitro
amplification of nucleic acids. The system has
been designed to amplify either the 16S rRNA
gene sequence for mycobacteria or the insertion
element IS6110 for M.tuberculosis. The main
advantage of this method is that it works at a
single temperature which eliminates the need for
expensive thermal cyclers required by the PCR
method. Additionally, it is not susceptible to
contaminating ribonuclease activity which is a
major problem in clinical samples. However,
isothermal techniques require additional restric-
tion enzymes which may increase the overall cost
of the procedure. It should also be borne in mind
that this procedure is still being evaluated19.10.
MOLECULAR BASIS OF DRUG RESISTANCE
Since multi drug resistant tuberculosis strains
(i.e. resistance to at least rifampicin and isoni-
azid) are rapidly emerging and further burden-
ing the already considerable global tuberculosis
problem, it is becoming imperative to rapidly
diagnose drug resistant M. tuberculosis strains11.
In contrast to other bacteria, drug resistance in
M.tuberculosis is not plasmid mediated. Al-
though molecular events that are responsible for
drug resistance have not been well defined in all
cases, recent studies have shown a tremendous
progress. INH resistant mutants of M.tuberculosis
strains frequently showed catalase negative phe-
notype which could be attributed to deletion or
some point mutation in Kat G gene12.13. Recently,
resistance to rifampicin was found to be deter-
mined by mutations causing change in the rpo B
gene coding for beta-sub unit of RNA polymer-
ase14.
Streptomycin-resistant mutants show alterations
in the ribosomal protein S12 and/or in the highly
conserved rspl gene, which encodes the S12
ribosomal protein15. The single amidase enzyme
with both pyrazinamidase (PZase) and
nicotinamidase activities in M.tuberculosis is
the target for pyrazinamide. The mutations in
pnc A gene encoding the amidase enzyme con-
fers resistance to pyrazinamide in M.tuberculosis
complex16. Quinolones and coumarins are the
known inhibitors of the DNA gyrase. The gyrA
PCR results can be
obtained within 24
hoursof receiptof the
sample
The mutations in pnc
A gene encoding the
amidase enzyme
confers resistance to
pyrazinamide in
M. tuberculosis
complex.
chemiluminescent (non-radioactive) label and
the hybridized and unhybridized probe are sepa-
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mutations have been found to be associated with
resistance to quinolones17.
Techniques such as single strand cellular poly-
morphism (SSCP) could identify mutations in
short piece of DNA.  DNA of interest could be
amplified by the Polymerase Chain Reaction
(PCR). The PCR-SSCP technique has been suc-
cessfully explored for the detection of mutations
in the rifampicin resistance and also resistance
for streptomycin and quinolones18.
A new technique called the Line Probe Assay
(LiPA) also has been evolved using PCR to
amplify the region of RNA polymerase involved
in rigampicin resistance. A set of oligonucleotide
probes are immobilised onto a membrance strip
and rifampicin resistnce can be assessed from
the pattern obtained following hybridization.
This technique is undergoing rigorous analysis
at the moment19.
Phage reporterassay
In this technique, viable mycobacteria are in-
fected with specific reporter phages expressing
firefly luciferase gene Easily detectable signals
are apparent a few minutes after infection of
M.tuberculosis with reporter phages.  Light pro-
duction requires metabolically active
M.tuberculosis cells, in which reporter phages
replicate and luciferase gene is expressed.  When
drug-susceptible M.tuberculosis strains are in-
cubated with specific anti-tuberculosis drugs,
they fail to produce light after infection with
luciferase reporter phages. In contrast, drug-
resistant strains are unaffected by the drugs and
produce light at levels equivalent to those docu-
mented for untreated controls after infection
with reporter phages. This procedure may reduce
the time required for susceptibility testing of
M.tuberculosis strains. The applicability of this
technique to drug susceptibility testing of non-
tuberculous mycobacteria is yet to be explored20,21.
An evaluation of a new rapid bacteriophage
based method for the drug susceptibility testing
of M.tuberculosis has been reported recently by
Wilson et al by the Pha B assay.  The concept of
this assay is based on the ability of viable
M.tuberculosis bacilli to protect infecting
mycobacteriophage from inactivation by
phagocidal chemicals. It follows that after incu-
bation with drugs only those M.tuberculosis that
remain viable (i.e are drug resistant) can protect
the mycobacteriophage. Any mycobacteriophage
protected within viable bacilli replicate and ulti-
mately lyse their host.  For rapid detection, the
released mycobacteriophage are mixed with a
rapidly growing M.smegmatis host in which they
undergo rapid cycle of infection, replication and
lysis.  Lysis is easily seen as clear areas or plaques
in a lawn of rapid grower host. The number of
plaques generated from a given sample is directly
related to the number of protected
mycobacteriophage, which is dependent on the
number of M.tuberculosis bacilli that remain
viable after drug treatment21.
SKIN TESTS
Delayed type hypersensitivity (DTH) reaction
followed intradermal injection of a predeter-
mined amount of tuberculin or purified protein
derivative (PPD) remains the simplest and fre-
quently used method of inferring tuberculous
infection.  Although skin test does not discrimi-
nate between active tuberculosis, post infection
with mycobacteria or BCG vaccination, in the
diagnosis of tuberculosis it plays an important
role especially in association with contact his-
tory22.
ANTIBODY DETECTION
In this technique, antibodies against mycobacte-
rial antigens in sera from patients by Enzyme-
Linked Immunosorbent Assay (ELISA) is de-
tected using polyclonal or monoclonal antibodies.
When crude mycobac-terial preparation are used
for these tests, the test has low specificity.  False-
positive results are likely to be due to cross-
reactions by environ-mental mycobacteria and
other bacteria. To prepare purified antigens from
mycobacterial cultures, techniques such as ion-
exchange chromatography, gel filtration,
isoelectric focusing, electrophoresis and affinity
chroma-tography are required, purified antigens
improve the specificity of the antibody detection
assays.  However, reproducible methods for the
purification of mycobacterial antigens have yet
to be evolved which means that the results of such
assays are variable.  The most promising purified
antigen among those available so far are the
38kDa and Ag60 antigens from M.tuberculosis23.
At this point it is worthwhile to mention that the
immune response in mycobacterial disease ap-
pears to be associated with HLA class type II
Delayed type
hypersensitivity(DTH)
reaction followed
intradermal injection
of a predetermined
amount of tuberculin
or purified protein
derivative (PPD)
remains the simplest
and freqnetly used
method of inferring
tuberculous
infection.
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CONCLUSIONS
Today, many new techniques are available for the
diagnosis of tuberculosis and also for detection
and identification of mycobacteria. However,
detection of AFB by direct microscopy and iden-
tification of cultured mycobacteria by biochemi-
cal methods still remain the recommended meth-
ods.  Since about a third of children with
tuberculosis suffer from extrapulmonary disease,
it is necessary to culture all fluids and biopsy
specimens from appropriate body sites, where
the conventional methods may offer limited help.
Other non-specific tests such as white blood cell
count, differential count, sedimentation rate, lys-
ozyme assay, bromide-partition test, adenosine
deaminase assay and estimation of sugar and
protein may play a supportive role.  Faster culture
methods such as Bactec, MGIT are being in-
creasingly used mainly because they reduce the
time of culture to about 2 weeks.  Nucleic acid
amplification techniques are mainly for cases
where there is a change that the infection may be
due to a mycobacterium other than
M.tuberculosis.  It is also to be remembered that
most of the new techniques described involve
prohibitive expenditure in terms of instrumenta-
tion, expertise and reagents, putting them out
of the reach of many public health laboratories of
developing countries, especially India26.
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allotypes and different patients appear to recog-
nize different antigens24.  This suggests that it is
unlikely that all tuberculosis patients will recog-
nize a single antigen.  This may prove to be a
handicap as far at antibody-based detection sys-
tems for mycobacteria are concerned25.
